Menu

Korsana Biosciences, Inc. KRSA

Full chart Compare
Set alert

Price alert · KRSA

All alert types
31.05 USD +0.62 (+2.04%)

At closeNov 6, 2026, 4:00 PM EST

31.05 0.00 0.00%

After hours · Nov 6, 4:00 PM ET

29.70 Day range 31.20
7.19 52-week range 59.36
YTD
+249.27%
1 year
+162.47%

Revenue & Expenses

Other Income → Expenses: $1.45MExpenses → Selling, General & Admin: $6.09MExpenses → Research & Development: $959.00KGross Profit → Expenses: $2.07MRevenue → Gross Profit: $2.07MNet Loss → Expenses: $3.53MOther Income$1.45MGross Profit$2.07MNet Loss$3.53MExpenses$7.05MSelling, General & Admin$6.09MResearch & Development$959.00KRevenue$2.07M

Latest period ending Dec 31, 2025 · select a line to chart its full history

KRSA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
2.07M2.00M0297.00K3.94M
2.07M2.00M0297.00K3.94M
-4.97M-3.63M-12.95M-18.54M-55.20M
-3.53M-3.06M-5.26M-44.08M-51.65M
-7.80-8.50-15.80-142.00-185.00
KRSA annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
154.13M3.23M7.57M13.38M53.96M
154.60M9.57M13.37M18.08M59.33M
13.03M725.00K2.09M7.63M11.09M
-33.97M8.85M11.29M10.45M48.25M
KRSA annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-3.31M-4.33M-21.25M-40.61M-36.52M
3.32M05.02M29.00K30.79M
8.00K-4.34M-5.81M-40.58M-4.27M